(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.20%) $10.86
(0.00%) $0.792
(0.01%) $92.59
@ $0.771
Issued: 14 Feb 2024 @ 13:55
Return: -10.00%
Previous signal: Feb 13 - 15:34
Previous signal:
Return: -0.05 %
Live Chart Being Loaded With Signals
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States...
Stats | |
---|---|
Today's Volume | 1.19M |
Average Volume | 3.19M |
Market Cap | 89.66M |
EPS | $0 ( 2024-03-27 ) |
Next earnings date | ( $-0.480 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.250 |
ATR14 | $0.00400 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Touchon Pascal | Sell | 24 844 | Common Stock |
2024-03-04 | Nguyen Anhco | Sell | 10 746 | Common Stock |
2024-03-04 | Murugan Amar | Sell | 10 044 | Common Stock |
2024-03-04 | Hyllengren Eric J | Sell | 1 462 | Common Stock |
2024-03-04 | Hyllengren Eric J | Sell | 5 217 | Common Stock |
INSIDER POWER |
---|
66.03 |
Last 100 transactions |
Buy: 7 600 944 | Sell: 2 114 657 |
Volume Correlation
Atara Biotherapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
SRTS | 0.965 |
CDXS | 0.964 |
LGHL | 0.959 |
ZD | 0.957 |
ZYNE | 0.952 |
RKDA | 0.95 |
ATER | 0.949 |
HNNA | 0.948 |
NMTR | 0.948 |
DYNT | 0.946 |
10 Most Negative Correlations | |
---|---|
MCAA | -0.951 |
MSDA | -0.949 |
CITE | -0.945 |
DHAC | -0.944 |
AHRN | -0.942 |
LEGA | -0.942 |
ADAL | -0.942 |
FTAA | -0.94 |
PFTA | -0.939 |
ZING | -0.939 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Atara Biotherapeutics Inc Correlation - Currency/Commodity
Atara Biotherapeutics Inc Financials
Annual | 2022 |
Revenue: | $63.57M |
Gross Profit: | $49.01M (77.08 %) |
EPS: | $-2.24 |
Q3 | 2023 |
Revenue: | $2.14M |
Gross Profit: | $-477 000 (-22.31 %) |
EPS: | $-0.660 |
Q2 | 2023 |
Revenue: | $957 000 |
Gross Profit: | $-1.94M (-202.51 %) |
EPS: | $-0.680 |
Q1 | 2023 |
Revenue: | $1.23M |
Gross Profit: | $1.01M (82.38 %) |
EPS: | $-0.720 |
Financial Reports:
No articles found.
Atara Biotherapeutics Inc
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators